Tag: Drug Development

Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery. It includes pre-clinical research on microorganisms and animals, filing for regulatory status for an investigational new drug to initiate clinical trials on humans, and may include the step of obtaining regulatory approval with a new drug application to market the drug.

Avacta and ADC Therapeutics Join Forces to Develop Drug Conjugates

lab research
Pharma company Avacta Group PLC has signed a collaboration agreement with Swiss biotechnology firm ADC Therapeutics SA. Avacta’s lead candidate is Affimer, an alternative to antibodies, derived fro...

Innovent Biologics and Hutchison China MediTech Expand Global Collaboration Agreement

Innovent Biologics, Inc. and Hutchison China MediTech Limited announced the expansion of their global collaboration agreement to evaluate the safety and efficacy of Innovent’s Tyvyt® (sintilimab injec...

Numab and Eisai Agreed to Discover and Develop Multi-Specific Antibody Immunotherapies for Cancer

drug development
Numab Therapeutics AG announced the initiation of a partnership with Eisai, Co., Ltd (Eisai), under a research and option agreement, to discover and develop novel multi-specific antibody immunotherapi...

Chimerix Entered into Exclusive Global License Agreement with SymBio Pharmaceuticals

drug-development
Chimerix, a development-stage biopharmaceutical company dedicated to accelerating the advancement of innovative medicines that make a meaningful impact in the lives of patients living with cancer and ...

BI and Inflammasome Entered into Co-Development and License Agreement

Boehringer Ingelheim and Inflammasome Therapeutics Inc. announced they have entered into a co-development and license agreement to develop up to three therapies for patients with retinal diseases. By ...

Astellas and iota Biosciences Announce Joint Research and Development Agreement

deal
Astellas Pharma Inc. and iota Biosciences, Inc. announced a joint research and development agreement to explore new biosensing and treatment measures using ultra-small implantable medical devices. Und...

Enable Injections Entered into Development Agreement with Genentech

Enable Injections has entered into a development agreement with Genentech. This partnership includes the potential for multiple molecule development programs including enFuse, under development by Ena...

Novo Holdings Invests over $10m in New Antibiotics’ Development

Small-molecule therapeutics company Curza received $5.25 million from the Novo Holdings REPAIR Impact Fund to help accelerate its lead programme focusing on a new class of antibiotics targeting drug-r...

Servier Australia and BioCurate Agreed to Share Expertise to Accelerate the Discovery of New Drugs

Servier Australia, the subsidiary of Servier Group, an international pharmaceutical company, and BioCurate, a joint venture company of Monash University and The University of Melbourne with support fr...

Cooperation on Development of Immuno-Oncology Therapies Announced by Gilead and Carna Biosciences

gilead sciences
Gilead Sciences, Inc. and Carna Biosciences Inc. announced that the companies have entered into a research and development collaboration to develop and commercialize small molecule compounds in immuno...

Cytel and Axio to Create Industry Leader in Analytical Solutions for Drug Development

Cytel Inc., the leading global provider of innovative analytical software and services to the life sciences industry, and Axio Research, a premier provider of biostatistics to pharmaceutical, biotechn...

Teijin and AMED Agreed Partnership to Develop Drugs for Frail

Teijin Limited announced that it has signed a research and development agreement with the Japan Agency for Medical Research and Development (AMED) to form an industry-government-academia partnership t...

AstraZeneca Announce Cooperation to Accelerate Drug Discovery

astrazeneca
AstraZeneca and BenevolentAI began a long-term collaboration to use artificial intelligence (AI) and machine learning for the discovery and development of new treatments for chronic kidney disea...

LabCorp and Envigo in Acquisition Deal

LabCorp®, a leading global life sciences company that is deeply integrated in guiding patient care, and Envigo, a leading provider of nonclinical contract research services and research models, announ...

Launch of Medicines Discovery Institute for Novel Meds Development

With the launch of Medicines Discovery Institute, Cardiff University has stepped up the development of new drugs for mental health and central nervous system conditions. The new institute aims to deve...

PPD and HLT of China in Exclusive Agreement

Pharmaceutical Product Development, LLC (PPD) and Happy Life Tech (HLT) of China have signed an exclusive agreement to develop a distinctive service offering for the China drug-development market deli...